Monday, September 19, 2016 10:22:10 PM
Lympro was a bust nothing promised of revenue ever came true or CLIA lab certification.
Eltoprazine was halted and still not performing
MANF has that even started in the clinic yet?
ESS is shady. Look at the clinical trials .gov website has a due date of results in 2020 as a phase 2 for a recruitment of what? 10 patients. The final results are expected July 2020, and that's if it starts. The trial is in the " not yet recruiting" status. That means once it starts recruiting if it does this year the results won't be out until 2021. This company is a shell corporation along with another biotech known as BMSN. Look it up. There's a reason why these trade on the pink sheets.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM